Titan PharmaceuticalsTTNP
13F holders, Q1 2025 (March 31)17holders +2
3new positions
1sold out
1famous investor
$3.53avg. 13F price*
At the end of Q1 2025, 17 institutions reported holding Titan Pharmaceuticals Inc. (TTNP) in their 13F filings, up 2 from Q4 2024. 3 opened new positions and 1 sold out. The largest holders were Citadel Advisors ($42K), UBS Group AG ($9K) and CoreCap Advisors, LLC ($311). One famous investor held it Ken Griffin (0.0% of Citadel Advisors's portfolio).
- Company
- Titan Pharmaceuticals Inc.
- CUSIP
- 888314705
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q4 2024 → Q1 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 3 | $43K |
| Exits | 1 | $538 |
All 13F filers, Q4 2024 → Q1 2025: 12,057 shares bought and 238 shares sold, net +11,819 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 17 holders
| Citadel Advisors | 0.00% | New | 11,961 | $42K |
| UBS Group AG | 0.00% | Reduce -2.7% | 2,594 | $9K |
| CoreCap Advisors, LLC | 0.00% | New | 88 | $311 |
| Bank of America Corp. | 0.00% | Add +5.9% | 18 | $64 |
| Osaic Holdings, Inc. | 0.00% | No change | 15 | $49 |
| Group One Trading LLC | 0.00% | No change | 12 | $42 |
| BlackRock, Inc. | 0.00% | New | 6 | $21 |
| Morgan Stanley | 0.00% | Add +33.3% | 4 | $15 |
| Global Wealth Strategies & Associates | 0.00% | No change | 2 | $7 |
| Wells Fargo & Company | 0.00% | No change | 1 | $4 |
| Caldwell Sutter Capital, Inc. | 0.00% | No change | 1 | $4 |
| St Germain D J Co. Inc. | 0.00% | No change | 1 | $4 |
| Westside Investment Management, Inc. | 0.00% | No change | 1 | $4 |
| SBI Securities Co., Ltd. | 0.00% | No change | 1 | $4 |
| Cape Investment Advisory, Inc. | 0.00% | No change | 1 | $4 |
| Nemes Rush Group LLC | 0.00% | No change | 1 | $4 |
| Ransom Advisory, Ltd | 0.00% | No change | 1 | $4 |
"% of holder's portfolio" is TTNP's weight in each manager's 13F, not the share of Titan Pharmaceuticals Inc. the manager owns.